Abstract:Necroptosis and pyroptosis are two forms of regulated cell death. They are executed by the proteins mixed-lineage kinase domain-like (MLKL) and gasdermin D (GSDMD), respectively. Once activated by numerous pathways, these proteins form membrane pores that allow the influx and efflux of various ions, proteins, and water, ultimately resulting in the death of the cell. These modalities of cell death are considered highly inflammatory because of the release of inflammatory cytokines and damage-associated molecular patterns, and are thereby not only deleterious for the dying cell itself, but also its environment or the entire organism. The relevance for these processes has been observed in various physiological and pathophysiological conditions, ranging from viral and bacterial infections over autoimmune and chronic inflammatory diseases to ischemic organ damage. In recent years, initial in vitro experiments have shed light on a range of connections between necroptosis and pyroptosis. Initial in vivo studies also indicate that, in many disease models, these two forms of cell death cannot be considered individually, as they demonstrate a complex interaction. In this article, we provide an overview of the currently known structure, pathways of activation, and functions of MLKL and GSDMD. With emerging evidence for an interconnection between necroptosis and pyroptosis in not only in vitro, but also in vivo models of disease, we highlight in particular the clinical relevance of the crosslinks between these two forms of inflammatory cell death and their implications for novel therapeutic strategies in a variety of diseases.

Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

Plasma Membrane Pores Drive Inflammatory Cell Death

The gasdermins, a protein family executing cell death and inflammation

Gasdermins as evolutionarily conserved executors of inflammation and cell death

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

The gasdermin family: emerging therapeutic targets in diseases

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

Molecular and Structural Aspects of Gasdermin Family Pores and Insights into Gasdermin-Elicited Programmed Cell Death

Gasdermin E: A Prospective Target for Therapy of Diseases

Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis

Gasdermins and pannexin-1 mediate pathways of chemotherapy-induced cell lysis in hematopoietic malignancies

Gasdermins and pyroptosis in the kidney

Biological events and molecular signaling following MLKL activation during necroptosis

Gasdermin D:The killer protein performs cell pyroptosis

Microbial gasdermins: More than a billion years of pyroptotic-like cell death

The Many Faces of MLKL, the Executor of Necroptosis

Gasdermin D in pyroptosis

The Regulation and Modification of GSDMD Signaling in Diseases

Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis

Gasdermins: a dual role in pyroptosis and tumor immunity